MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
This study has been terminated.
(Withdrawn as trial was never activated by SuperGen)
Sponsor:
Astex Pharmaceuticals
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00504205
First received: July 17, 2007
Last updated: March 16, 2010
Last verified: April 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |